Note - The product information found within this database originates from organizations not subject to the Official Languages Act and is available in the language in which it was written and submitted to Health Canada.

Note - The market status of a product is now available in the LNHPD and identifies if a product is "marketed" or "not marketed" in Canada. Product licence holders may voluntarily provide the Natural and Non-Prescription Health Products Directorate (NNHPD) with information about whether their product is currently available to Canadian consumers. Where no information has been provided, the default status is "not marketed". The "current status" field remains unaffected and will continue to indicate the status of the product licence (i.e., active, discontinued, stop sale, cancelled, or suspended). Note that where a licence has been suspended, cancelled or under stop sale, the product cannot be legally sold in Canada.

Product licence holders - if you wish to update a product's market status, you are invited to complete the Natural Health Products Market Notification Web Form. As with all other notifications, there is no current service standard. The NNHPD will process the market status update as soon as feasible, based on its available resources. As a reminder, market notification is voluntary; therefore, a licence holder is not required to wait for the LNHPD to be updated before a licensed product is sold in Canada. As such, products that are identified in the LNHPD as "not marketed" may still be sold in Canada.

New search

Natural Product Number (NPN):

80034529

Market status:

Marketed

Licence Status:

Active

Brand name(s):

Cystoplus Sodium Citrate Powder

Licence holder:

PendoPharm, Division of/de Pharmascience Inc.

Dosage Form:

Powder

Recommended route of administration:

Oral

Recommended use or purpose:

Symptomatic relief of burning and stinging associated with cystitis in adult women.

Risk Information:

Cautions and Warnings 

Consult a doctor prior to use if you have any of the following conditions: heart disease, kidney disease, high blood pressure, or diabetes or if you have other underlying or ongoing health concerns. Inform your doctor prior to use if you are taking other medications, especially ACE inhibitors, diuretics or cyclosporine. Do not take more that three sachets in one day. If you accidently take more Cystoplus Sodium Citrate Powder than recommended, seek medical advice immediately. Use caution when administering to the elderly.

Contra-Indications 

Do not use if you are taking lithium of hexamine, are on a low-sodium diet, or are sensitive to any of the ingredients. Do not use if pregnant or breast-feeding. Not recommended for use in men and children.

Known Adverse Reactions 

Flatulence Frequent urination.

List of medicinal ingredients:

Medicinal ingredients	Quantity (Qty)	Extract	Potency
Sodium citrate	4.0 g

List of non-medicinal ingredients:

• Amaranth
• Colloidal silicon dioxide
• Cranberry flavour
• Saccharin sodium
• Sucrose

Date of licensing:

2012-08-10

Revised date of licence:

2017-11-08